Metropolis completes acquisition of four individual laboratories in Gujarat Since acquisition Metropolis strength in Gujarat has grown four times
Metropolis records revenue growth of 18.1 per cent in FY19 One of the key growth parameters is 15.5 per cent growth in number of patient visits with increase in revenue per patient (5.4 per…
Right time for IPOs? As we go to press in end April, Dr A Velumani's Thyrocare Technologies (Thyrocare) looks set to have a successful debut on the…
Metropolis Healthcare announces price slash for Swine Flu testing It is one of the few select labs authorised for Swine Flu testing Metropolis Healthcare is offering Swine Flu test at Rs 4000.…